Evidence map›Paper›PMID 24376278›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2014

Prequit fMRI responses to pleasant cues and cigarette-related cues predict smoking cessation outcome.

Francesco Versace, Jeffrey M Engelmann, Jason D Robinson, Edward F Jackson, Charles E Green, Cho Y Lam, Jennifer A Minnix, Maher A Karam-Hage, Victoria L Brown, David W Wetter and 1 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00507728 (Pharmacogenetics, Emotional Reactivity and Smoking), which is not on this map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00507728 phase2 / phase3completednot on this map

Pharmacogenetics, Emotional Reactivity and Smoking

TypeinterventionalSponsorM.D. Anderson Cancer CenterRan2005 to 2019Enrolled646ConditionsTobacco Use Disorder, Smoking CessationArmsBupropion, Varenicline, Placebo, Smoking Cessation Counseling
3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Vaping and Smoking Cue Reactivity in Young Adult Nonsmoking Electronic Cigarette Users: A Functional Neuroimaging Study.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Francesco VersaceUniversity of Texas MD Anderson Cancer Center, Houston, TX;
Jeffrey M Engelmann
Jason D Robinson
Edward F Jackson
Charles E Green
Cho Y Lam
Jennifer A Minnix
Maher A Karam-Hage
Victoria L Brown
David W Wetter
Paul M Cinciripini
The University of Texas MD Anderson Cancer Center · USThe University of Texas Health Science Center at Houston · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
R25 SUPPLEMENT IN GENETIC EPIDEMIOLOGY EDUCATIONR25CA057730 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHANG, SHINE · 1992 to 2016
$18.6M
Pharmacogenetics, Emotional Reactivity &Smoking(RMI)R01DA017073 · NIDA · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CINCIRIPINI, PAUL MICHAEL · 2004 to 2009
$3.0M
Incentive salience and the neuropsychological underpinnings of cue-induced smoking relapseR01DA032581 · NIDA · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI VERSACE, FRANCESCO · 2012 to 2024
$2.5M
NCI NIH HHS CA016672NCI NIH HHS P30 CA016672NCI NIH HHS R25-T CA057730NIDA NIH HHS 1R01DA017073-S1NIDA NIH HHS R01 DA032581
6 · The paper itself

Abstract

introductionThe reasons that some smokers find it harder to quit than others are unclear. Understanding how individual differences predict smoking cessation outcomes may allow the development of more successful personalized treatments for nicotine dependence. Theoretical models suggest that drug users might be characterized by increased sensitivity to drug cues and by reduced sensitivity to nondrug-related natural rewards. We hypothesized that baseline differences in brain sensitivity to natural rewards and cigarette-related cues would predict the outcome of a smoking cessation attempt.

methodsUsing functional magnetic resonance imaging, we recorded prequit brain responses to neutral, emotional (pleasant and unpleasant), and cigarette-related cues from 55 smokers interested in quitting. We then assessed smoking abstinence, mood, and nicotine withdrawal symptoms during the course of a smoking cessation attempt.

resultsUsing cluster analysis, we identified 2 groups of smokers who differed in their baseline responses to pleasant cues and cigarette-related cues in the posterior visual association areas, the dorsal striatum, and the medial and dorsolateral prefrontal cortex. Smokers who showed lower prequit levels of brain reactivity to pleasant stimuli than to cigarette-related cues were less likely to be abstinent 6 months after their quit attempt, and they had higher levels of negative affect during the course of the quit attempt.

conclusionsSmokers with blunted brain responses to pleasant stimuli, relative to cigarette-related stimuli, had more difficulty quitting smoking. For these individuals, the lack of alternative forms of reinforcement when nicotine deprived might be an important factor underlying relapse. Normalizing these pathological neuroadaptations may help them achieve abstinence.

Indexed as

CuesRewardAdultBrainEmotionsFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedRandomized Controlled Trials as TopicSmokingSmoking CessationSubstance Withdrawal SyndromeTobacco ProductsTobacco Use Disorder

Identifiers

PMID24376278
PMCPMC4015090
OpenAlexW2003885723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.